Why Danaher Shares Are Falling Today

Loading...
Loading...
  • Danaher Corp (NYSE: DHR) has logged Q1 FY23 adjusted EPS of $2.36, down from $2.76 a year ago, surpassing the consensus of $2.25.
  • Sales decreased 7% Y/Y to $7.17 billion, beating the consensus of $7.02 billion, with a 4% non-GAAP core revenue decrease, due to lower COVID-19 revenue and 6.0% non-GAAP base business core revenue growth. 
  • Operating cash flow for Q1 FY23 reached $1.9 billion. Non-GAAP free cash flow reached $1.7 billion.
  • Rainer M. Blair, President & CEO, stated, "We had a good start to the year in the first quarter. Our team's focused execution in a challenging operating environment helped deliver better-than-expected revenue, earnings and cash flow. We are especially pleased with the performance of our base business, which grew 6.0% in the first quarter."
  • The gross margin remained almost unchanged at 61%.
  • According to a report last week, Danaher was no longer considering a takeover of contract manufacturer Catalent Inc CTLT after expressing interest in buying the company earlier this year.
  • Outlook: For the Q2 and full year 2023, Danaher anticipates that non-GAAP base business core revenue growth will be up mid-single digits year-over-year.
  • For FY23, the company earlier expected non-GAAP base business core revenue to be up high-single digits.
  • Price Action: DHR shares are down 4.17% at $243.75 during the premarket session on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareMoversGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...